Objective:The aim of this study was to investigate the clinical,radiographic and histiopathologic features of multicentric giant cell tumor of bone.Methods:All the clinical data of twenty tumors in nine patients of mu...Objective:The aim of this study was to investigate the clinical,radiographic and histiopathologic features of multicentric giant cell tumor of bone.Methods:All the clinical data of twenty tumors in nine patients of multicentric giant cell tumor that underwent surgical treatment in our department from 1990 to 2010 were retrospectively reviewed,which included three males and six females.The patients ranged from 15 to 45 years at diagnosis,with an average age of 22.3 years.Three of the patients were younger than twenty years of age.Most tumors arose in long bones,especially around the knee.Radiographically,the tumors in long bones usually manifested as expansive lytic lesions involving the metaphysis and extending into the epiphysis.Three tumors in three patients were confined to the metaphysis,and one tumor exhibited bone-forming lesions.All tumors were treated with curettage or resection.Results:The typical "giant cell" could be found in the oncologic examination in all cases.In some areas,such as the fibrohistiocytic regions,reactive bone forming and aneurysmal bone cyst-like changes could be found.Follow-up averaged 3.5 years,ranging from 6 months to 12 years.There was a recurrence of three tumors,and one patient died of pulmonary metastasis.Conclusion:Multicentric giant cell tumor occur often in younger patients than do solitary giant cell tumor.They are frequently present around the knee,and confined to the metaphysis.Each tumor arose independently,rather than being in multiple sites of metastatic lesion that develop from a single tumor.The risk of recurrence depends on the type of surgery that is performed.展开更多
As a surgical method for the treatment of adrenal surgical diseases,laparoscopy has the advantages of small trauma,short operation time,less bleeding,and fast postoperative recovery.It is considered as the gold standa...As a surgical method for the treatment of adrenal surgical diseases,laparoscopy has the advantages of small trauma,short operation time,less bleeding,and fast postoperative recovery.It is considered as the gold standard for the treatment of adrenal surgical diseases.Retroperitoneal laparoscopy is widely used because it does not pass through the abdominal cavity,does not interfere with internal organs,and has little effect on gastrointestinal function.However,complex adrenal tumors have the characteristics of large volume,compression of adjacent tissues,and invasion of surrounding tissues,so they are rarely treated by retroperitoneal laparoscopy.In recent years,with the development of laparoscopic technology and the progress of surgical technology,robotic surgery has been gradually applied to the surgical treatment of complex adrenal tumors.This paper reviews the clinical application of retroperitoneal laparoscopic surgery and robotic surgery in the treatment of complex adrenal tumors.展开更多
AIM: To investigate potential therapeutic recommendations for endoscopic and surgical resection of T1a/ T1b esophageal neoplasms. METHODS: A thorough search of electronic databases MEDLINE, Embase, Pubmed and Cochrane...AIM: To investigate potential therapeutic recommendations for endoscopic and surgical resection of T1a/ T1b esophageal neoplasms. METHODS: A thorough search of electronic databases MEDLINE, Embase, Pubmed and Cochrane Library, from 1997 up to January 2011 was performed. An analysis was carried out, pooling the effects of outcomes of 4241 patients enrolled in 80 retrospective studies. For comparisons across studies, each reporting on only one endoscopic method, we used a random effects meta-regression of the log-odds of the outcome of treatment in each study. "Neural networks" as a data mining technique was employed in order to establish a prediction model of lymph node status in superficial submucosal esophageal carcinoma. Another data mining technique, the "feature selection and root cause analysis", was used to identify the most impor-tant predictors of local recurrence and metachronous cancer development in endoscopically resected patients, and lymph node positivity in squamous carcinoma (SCC) and adenocarcinoma (ADC) separately in surgically resected patients. RESULTS: Endoscopically resected patients: Low grade dysplasia was observed in 4% of patients, high grade dysplasia in 14.6%, carcinoma in situ in 19%, mucosal cancer in 54%, and submucosal cancer in 16% of patients. There were no significant differences between endoscopic mucosal resection and endoscopic submucosal dissection (ESD) for the following parameters: complications, patients submitted to surgery, positive margins, lymph node positivity, local recurrence and metachronous cancer. With regard to piecemeal resection, ESD performed better since the number of cases was significantly less [coefficient: -7.709438, 95%CI: (-11.03803, -4.380844), P < 0.001]; hence local recurrence rates were significantly lower [coefficient: -4.033528, 95%CI: (-6.151498, -1.915559),P < 0.01]. A higher rate of esophageal stenosis was observed following ESD [coefficient: 7.322266, 95%CI: (3.810146, 10.83439), P < 0.001]. A significantly greater number of SCC patients were submitted to surgery (log-odds, ADC: -2.1206 ± 0.6249 vs SCC: 4.1356 ± 0.4038, P < 0.05). The odds for re-classification of tumor stage after endoscopic resection were 53% and 39% for ADC and SCC, respectively. Local tumor recurrence was best predicted by grade 3 differentiation and piecemeal resection, metachronous cancer development by the carcinoma in situ component, and lymph node positivity by lymphovascular invasion. With regard to surgically resected patients: Significant differences in patients with positive lymph nodes were observed between ADC and SCC [coefficient: 1.889569, 95%CI: (0.3945146, 3.384624), P<0.01). In contrast, lymphovascular and microvascular invasion and grade 3 patients between histologic types were comparable, the respective rank order of the predictors of lymph node positivity was: Grade 3, lymphovascular invasion (L+), microvascular invasion (V+), submucosal (Sm) 3 invasion, Sm2 invasion and Sm1 invasion. Histologic type (ADC/SCC) was not included in the model. The best predictors for SCC lymph node positivity were Sm3 invasion and (V+). For ADC, the most important predictor was (L+). CONCLUSION: Local tumor recurrence is predicted by grade 3, metachronous cancer by the carcinoma insitu component, and lymph node positivity by L+. T1b cancer should be treated with surgical resection.展开更多
文摘Objective:The aim of this study was to investigate the clinical,radiographic and histiopathologic features of multicentric giant cell tumor of bone.Methods:All the clinical data of twenty tumors in nine patients of multicentric giant cell tumor that underwent surgical treatment in our department from 1990 to 2010 were retrospectively reviewed,which included three males and six females.The patients ranged from 15 to 45 years at diagnosis,with an average age of 22.3 years.Three of the patients were younger than twenty years of age.Most tumors arose in long bones,especially around the knee.Radiographically,the tumors in long bones usually manifested as expansive lytic lesions involving the metaphysis and extending into the epiphysis.Three tumors in three patients were confined to the metaphysis,and one tumor exhibited bone-forming lesions.All tumors were treated with curettage or resection.Results:The typical "giant cell" could be found in the oncologic examination in all cases.In some areas,such as the fibrohistiocytic regions,reactive bone forming and aneurysmal bone cyst-like changes could be found.Follow-up averaged 3.5 years,ranging from 6 months to 12 years.There was a recurrence of three tumors,and one patient died of pulmonary metastasis.Conclusion:Multicentric giant cell tumor occur often in younger patients than do solitary giant cell tumor.They are frequently present around the knee,and confined to the metaphysis.Each tumor arose independently,rather than being in multiple sites of metastatic lesion that develop from a single tumor.The risk of recurrence depends on the type of surgery that is performed.
文摘As a surgical method for the treatment of adrenal surgical diseases,laparoscopy has the advantages of small trauma,short operation time,less bleeding,and fast postoperative recovery.It is considered as the gold standard for the treatment of adrenal surgical diseases.Retroperitoneal laparoscopy is widely used because it does not pass through the abdominal cavity,does not interfere with internal organs,and has little effect on gastrointestinal function.However,complex adrenal tumors have the characteristics of large volume,compression of adjacent tissues,and invasion of surrounding tissues,so they are rarely treated by retroperitoneal laparoscopy.In recent years,with the development of laparoscopic technology and the progress of surgical technology,robotic surgery has been gradually applied to the surgical treatment of complex adrenal tumors.This paper reviews the clinical application of retroperitoneal laparoscopic surgery and robotic surgery in the treatment of complex adrenal tumors.
文摘AIM: To investigate potential therapeutic recommendations for endoscopic and surgical resection of T1a/ T1b esophageal neoplasms. METHODS: A thorough search of electronic databases MEDLINE, Embase, Pubmed and Cochrane Library, from 1997 up to January 2011 was performed. An analysis was carried out, pooling the effects of outcomes of 4241 patients enrolled in 80 retrospective studies. For comparisons across studies, each reporting on only one endoscopic method, we used a random effects meta-regression of the log-odds of the outcome of treatment in each study. "Neural networks" as a data mining technique was employed in order to establish a prediction model of lymph node status in superficial submucosal esophageal carcinoma. Another data mining technique, the "feature selection and root cause analysis", was used to identify the most impor-tant predictors of local recurrence and metachronous cancer development in endoscopically resected patients, and lymph node positivity in squamous carcinoma (SCC) and adenocarcinoma (ADC) separately in surgically resected patients. RESULTS: Endoscopically resected patients: Low grade dysplasia was observed in 4% of patients, high grade dysplasia in 14.6%, carcinoma in situ in 19%, mucosal cancer in 54%, and submucosal cancer in 16% of patients. There were no significant differences between endoscopic mucosal resection and endoscopic submucosal dissection (ESD) for the following parameters: complications, patients submitted to surgery, positive margins, lymph node positivity, local recurrence and metachronous cancer. With regard to piecemeal resection, ESD performed better since the number of cases was significantly less [coefficient: -7.709438, 95%CI: (-11.03803, -4.380844), P < 0.001]; hence local recurrence rates were significantly lower [coefficient: -4.033528, 95%CI: (-6.151498, -1.915559),P < 0.01]. A higher rate of esophageal stenosis was observed following ESD [coefficient: 7.322266, 95%CI: (3.810146, 10.83439), P < 0.001]. A significantly greater number of SCC patients were submitted to surgery (log-odds, ADC: -2.1206 ± 0.6249 vs SCC: 4.1356 ± 0.4038, P < 0.05). The odds for re-classification of tumor stage after endoscopic resection were 53% and 39% for ADC and SCC, respectively. Local tumor recurrence was best predicted by grade 3 differentiation and piecemeal resection, metachronous cancer development by the carcinoma in situ component, and lymph node positivity by lymphovascular invasion. With regard to surgically resected patients: Significant differences in patients with positive lymph nodes were observed between ADC and SCC [coefficient: 1.889569, 95%CI: (0.3945146, 3.384624), P<0.01). In contrast, lymphovascular and microvascular invasion and grade 3 patients between histologic types were comparable, the respective rank order of the predictors of lymph node positivity was: Grade 3, lymphovascular invasion (L+), microvascular invasion (V+), submucosal (Sm) 3 invasion, Sm2 invasion and Sm1 invasion. Histologic type (ADC/SCC) was not included in the model. The best predictors for SCC lymph node positivity were Sm3 invasion and (V+). For ADC, the most important predictor was (L+). CONCLUSION: Local tumor recurrence is predicted by grade 3, metachronous cancer by the carcinoma insitu component, and lymph node positivity by L+. T1b cancer should be treated with surgical resection.
文摘目的探讨新辅助化疗后保留肾单位手术(nephron sparing surgery,NSS)治疗单侧肾母细胞瘤的初步疗效。方法回顾性分析2014年1月至2020年12月复旦大学附属儿科医院收治的7例单侧肾母细胞瘤患儿临床资料,均行新辅助化疗及NSS。收集患儿生存率、肾功能以及肿瘤复发情况,并与同期行根治性肿瘤切除术(radical nephrectomy,RN)的患儿进行疗效比较。结果7例中,男4例、女3例,发病年龄(38.86±18.23)个月,无一例合并肿瘤相关综合征或半侧肢体肥大;肿瘤位于肾脏一极1例,肾脏中央6例。7例经新辅助化疗后,肿瘤体积缩小(66.4±18.6)%。1例肿瘤位于肾脏一极的患儿行部分肾切除术(partial nephrectomy,PN),6例肿瘤位于肾中央的患儿行肿瘤剜除术(tumor enucleation,TE),术后病理检查结果提示镜下肿瘤切缘阳性2例。儿童肿瘤国际协会(International Society for Pediatric Oncology,SIOP)分期:Ⅱ期4例、Ⅲ期3例。随访时间(38.42±10.17)个月,无一例失访或死亡。无瘤生存6例,带瘤生存1例。NSS后出现肿瘤复发2例。NSS后复发率(28.6%)及5年生存率(100%)与同期行RN的患儿复发率(13.3%)和5年生存率(86.9%)相比,差异均无统计学意义(P>0.05)。结论单侧肾母细胞瘤通过合理的术前评估和新辅助化疗,可以增加NSS的机会,并取得与RN相似的治疗效果。
